Assignee
GENOSCIENCE PHARMA
FR·4 granted patents·1 pending application·1 citations·filing 2014–2024
Top patents by PatentIndex Score
5 records- 0157US2025074885A1Crystalline freebase form of 2-(4-chlorobenzylamino)-4-(4-tert-butylaminopiperidin-1-yl)-quinoline and uses thereofGENOSCIENCE PHARMA·Filed 2024·Application pending·0 cites
- 0256US10179770B2Quinolines derivatives as novel anticancer agentsGENOSCIENCE PHARMA·Filed 2014·Granted Jan 15, 2019·1 cites·29 claims
- 0334US11261189B2Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and cathepsins B (CTSB), L (CTSL) and D (CTSD) related diseasesGENOSCIENCE PHARMA·Filed 2019·Granted Mar 1, 2022·0 cites·36 claims
- 0430US10577362B2Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proliferative diseasesGENOSCIENCE PHARMA·Filed 2017·Granted Mar 3, 2020·0 cites·31 claims
- 0523US10722505B2Substituted 2,4 diamino-quinoline as new anticancer agentsGENOSCIENCE PHARMA·Filed 2015·Granted Jul 28, 2020·0 cites·24 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →